Inflammatory Bowel Disease (IBD): New Perspectives

Inflammatory Bowel Disease Is Not Genetically Determined, Not Classically Autoimmune, and Not Idiopathic: A Critical Reframing of Pathogenesis
authors: Josh Dech, CHN; Yusuf J.P. Saleeby, MD
Challenges conventional explanations of inflammatory bowel disease and examines gene-environment interactions, immune function and potentially modifiable contributors to disease development.

• Perspective JIM

Volume 2, No. 4 (July 2026 issue); all previous issues of the Journal of Independent Medicine are available free of charge at www.JIndepMed.org.

Background: Inflammatory bowel disease (IBD) is conventionally explained as a genetically determined disorder, a classical autoimmune disease, or a largely idiopathic condition. Current evidence challenges all three.

Methods: Literature was searched from inception through January 2026 across epidemiology, genetics, immunology, and toxicology. IBD-associated antibodies were evaluated against the Rose and Bona criteria for classical autoimmunity. For mold and mycotoxin exposure, converging mechanisms were drawn from immunology and toxicology literature.

Results: First, IBD is not genetically determined. Heritability is modest (h2=0.25), only 20–40% of NOD2 homozygotes develop CD, twin concordance is 20–50%/10–19% for CD/UC, and immigrant children develop IBD at host-population rates within one generation. Prevalence has compounded from 2–4 to >1,000 per 100,000 (1950s-2035) in early industrialized countries, incompatible with monogenic determinism. Second, IBD fails classical autoimmune criteria. IBD-associated antibodies (ASCA, pANCA, anti-OmpC, anti-CBir1, anti-glycan ALCA/ACCA/AMCA) target microbial and environmental antigens, not self. Pathogenic transfer is not demonstrated, supporting an immune-mediated rather than autoimmune classification. Third, IBD is not idiopathic. Smoking (OR 1.76), antibiotic exposure (OR 1.74), urbanization, oral contraceptives, ultra-processed food, air pollution, and psychological stress are confirmed contributors. Shared mechanisms point to mold and mycotoxin exposure via Th17/Th1 polarization, NF-κB activation, and barrier disruption.

Conclusions: IBD is environmentally driven, immune-mediated rather than classically autoimmune, and partially heritable but not genetically determined. This reframing supports a prevention-oriented clinical and public health agenda.

Keywords: Inflammatory bowel disease, immune-mediated disease, genetic determinism, classical autoimmunity criteria, environmental triggers, mycotoxins